PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update
As a result of the approval of the Company's stockholders on
Previously these activities were scheduled for
Conference Call Details
We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10149211/db6bb6ea0d. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Those who choose not to pre-register can access the live conference by dialing (833) 685-0901 from
To access the live and subsequently archived webcast of the conference call, go to "Events & Presentations" on the Company's website. Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.
Throughout its history, PDL's mission has been to improve the lives of patients by aiding in the successful development of innovative therapeutics and healthcare technologies.
For more information please visit https://www.pdl.com/
View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-reschedules-third-quarter-2020-financial-results-and-business-update-301168097.html
LHA Investor Relations: Jody Cain, SVP, (310) 691-7100, firstname.lastname@example.org